Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts


Opportunity ID: 334360
Opportunity Number: RFA-DP-22-002
Opportunity Title: Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.283
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility: This NOFO is open competition
Agency Name: Department of Health and Human Services
Centers for Disease Control and Prevention – ERA
Posted Date: Jun 28, 2021
Last Updated Date: Jun 28, 2021
Estimated Synopsis Post Date: Nov 05, 2021
Fiscal Year: 2022
Award Ceiling: $900,000
Award Floor: $870,000
Estimated Total Program Funding: $22,000,000
Expected Number of Awards: 5
Description: The primary purpose of this opportunity is to fund applicants with existing access to adult lupus patient populations and can extend current knowledge over 12-17 years from baseline. A second component of this funding opportunity will focus on the pediatric lupus – to advance existing knowledge of lupus in pediatric populations using an existing cohort of lupus patients. Because lupus is a rare condition, it is efficient to obtain new information from existing relevant cohorts with lupus. The research objectives among both adult and pediatric populations are to: Examine the treatment (e.g., medications including opioid; type; appropriateness; etc.) of people with lupus. Determine health care access and gaps that people with lupus experience in addressing their varied health problems (e.g., general health problems as well as those for specific lupus outcomes, such as nephritis; transitions to adulthood). Determine longer term natural history (severity, chronic pain, progression, morbidity, mortality, disability and quality of life, work/ school/activity interference, etc.) of people with lupus, including assessing potential genetic factors. Examine other factors related to disparities in lupus outcomes (e.g., age, sex, and race/ethnic group). Examine lupus comorbidities.
Version: 1

Visit the Official Webpage For More Details on Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts


Please enter your comment!
Please enter your name here